 | Acurx Pharmaceuticals, Inc. | |||
| NCM : ACXP || Location: United States | ||||
$2.02-0.01 (-0.49%) |
0.09 M | 1.96 - 2.13 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.579 M |
| March 28, 2024 | 0.337 M |
| March 15, 2024 | 0.294 M |
| Feb. 29, 2024 | 0.292 M |
| Feb. 15, 2024 | 0.301 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.27 | -0.37 | -39.52% |
| 09/30/2023 | -0.28 | -0.24 | 12.85% |
| 06/30/2023 | -0.28 | -0.28 | -1.67% |
| 03/31/2023 | -0.30 | -0.25 | 16.92% |
| 12/31/2022 | -0.36 | -0.28 | 21.57% |
ACXP Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 15.757M | Shares Float | 13.352M |
| Short Float | 0.579M | Market Cap | 31.99M |
| Institution ownership | 11.74% | Insider ownership | 15.261% |
| Earnings Date | 05/15/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.15 | Forward EPS | -2.30 |